Clinical Trial Update: YM443 in Subjects With Functional Dyspepsia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for YM443 in subjects with functional dyspepsia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Functional Dyspepsia
• Indigestion
• Nausea

Drugs mentioned

• YM443

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Indigestion, Nausea | Phase 2 | Status: COMPLETED